Table 2 Radiation therapy, combination therapies, and discharge destination outcomes for all 277 cases and their relationship to patient prognoses
Factors | Patient numbers | Median PFS (months) | P values | Median OS (months) | P values | ||
|---|---|---|---|---|---|---|---|
All cases | 277 | 8.7 | 16.6 | ||||
RT | Conventional | 195 | (70.4%) | 9.0 | 0.000 | 17.7 | 0.000 |
Hypofractionation | 41 | (14.8%) | 7.3 | 8.6 | |||
WBRT | 5 | (1.8%) | 5.5 | 8.1 | |||
Proton | 33 | (11.9%) | 11.3 | 28.7 | |||
Not used | 3 | (1.1%) | 2.8 | 2.8 | |||
Combination therapies | TMZ | 180 | (65%) | 8.6 | 0.001 | 17.0 | 0.000 |
TMZ + BEV | 43 | (15.5%) | 8.7 | 11.0 | |||
TMZ + Immunotherapy | 39 | (14.1%) | 12.5 | 29.5 | |||
Others | 15 | (5.4%) | 5.5 | 10.2 | |||
Place after Discharge | Home | 144 | (52.0%) | 10.5 | 0.000 | 23.5 | 0.000 |
Trans | 130 | (46.9%) | 7.1 | 10.8 | |||
Death during hospitalization | 3 | (1.1%) | 2.7 | 2.7 |